CI

CDG International Company

Asia, Hong Kong Island, Hong Kong, Hong Kong

Description

CDG International Company

Investor Profile

CDG International Company has made 1 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series D (100%)

Country Focus

  • China (100%)

Industry Focus

  • Biopharma
  • Biotechnology
  • Health Care
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does CDG International Company frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 1
Loyal Valley Capital
Asia, Shanghai, China, Shanghai
Co-Investments: 1
Lake Bleu Capital
Asia, Hong Kong Island, Hong Kong, Hong Kong
Co-Investments: 1
AC
Asia, Hong Kong Island, Hong Kong, Central
Co-Investments: 1
Apricot Capital
Asia, Shanghai, China, Shanghai
Co-Investments: 1
K. Wah Group
Asia, Hong Kong Island, Hong Kong, Hong Kong
Co-Investments: 1
CCB Capital
Asia, Beijing, China, Beijing
Co-Investments: 1
BOCOM International
Asia, Hong Kong Island, Hong Kong, Central
Co-Investments: 1
Shenzhen Capital Group
Asia, Hunan, China, Nanshan
Co-Investments: 1
Sino Biopharmaceutical
Asia, Hong Kong Island, Hong Kong, Wan Chai
Co-Investments: 1

What are some of recent deals done by CDG International Company?

Akeso Biopharma

Zhongshan, Anhui, China

Akeso Biopharma is a biopharmaceutical company committed to the discovery, development, and commercialization of therapies.

BiopharmaBiotechnologyHealth Care
Series DNov 4, 2019
Amount Raised: $150,000,000